Imatinib
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB00619 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 9 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | systemic mastocytosis | TxGNN Knowledge Graph |
| 2 | dermatofibrosarcoma protuberans | TxGNN Knowledge Graph |
| 3 | idiopathic hypereosinophilic syndrome | TxGNN Knowledge Graph |
| 4 | hypereosinophilic syndrome | TxGNN Knowledge Graph |
| 5 | chronic myelogenous leukemia, BCR-ABL1 positive | TxGNN Knowledge Graph |
| 6 | chronic eosinophilic leukemia | TxGNN Knowledge Graph |
| 7 | chronic eosinophilic leukemia, not otherwise specified | TxGNN Knowledge Graph |
| 8 | mastocytosis | TxGNN Knowledge Graph |
| 9 | blast phase chronic myelogenous leukemia, BCR-ABL1 positive | TxGNN Knowledge Graph |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.